Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Vertex Pharmaceuticals Incorporated”

980 pharma patents match "Vertex Pharmaceuticals Incorporated" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 980
Index total 30,257
Page 24 / 41

Quick answer

This filtered view shows 980 pharmaceutical patents matching "Vertex Pharmaceuticals Incorporated" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

980 results for “Vertex Pharmaceuticals Incorporated” · 30,257 patents in full index Clear search

  1. US 8263605

    Modulators of muscarinic receptors

    Vertex Pharmaceuticals Incorporated · Granted Sep 11, 2012 · Expires Sep 6, 2032

    granted
  2. US 8263632

    Aminopyridine derivatives having Aurora A selective inhibitory action

    Vertex Pharmaceuticals Incorporated · Granted Sep 11, 2012 · Expires Sep 6, 2032

    granted
  3. US 8258148

    Spiroindoline modulators of muscarinic receptors

    Vertex Pharmaceuticals Incorporated · Granted Sep 4, 2012 · Expires Aug 30, 2032

    granted
  4. US 8258116

    Combination therapy for the treatment of HCV infection

    Vertex Pharmaceuticals Incorporated · Granted Sep 4, 2012 · Expires Aug 30, 2032

    granted
  5. US 8252541

    Sodium channel protein type III α-subunit splice variant

    Vertex Pharmaceuticals Incorporated · Granted Aug 28, 2012 · Expires Aug 23, 2032

    granted
  6. US 8252923

    Peptidomimetic protease inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Aug 28, 2012 · Expires Aug 23, 2032

    granted
  7. US 8252787

    Protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Aug 28, 2012 · Expires Aug 23, 2032

    granted
  8. US 8247532

    Deuterated hepatitis C protease inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Aug 21, 2012 · Expires Aug 16, 2032

    granted
  9. US 8247421

    5-cyano-4-(pyrrolo [2,3B] pyridine-3-yl)-pyrimidine derivatives useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Aug 21, 2012 · Expires Aug 16, 2032

    granted
  10. US 8242272

    Process for preparing 5-fluoro-1H-pyrazolo [3,4-B] pyridin-3-amine and derivatives thereof

    Vertex Pharmaceuticals Incorporated · Granted Aug 14, 2012 · Expires Aug 9, 2032

    granted
  11. US 8242149

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Aug 14, 2012 · Expires Aug 9, 2032

    granted
  12. US 8236815

    Ion channel modulators and methods of uses

    Vertex Pharmaceuticals Incorporated · Granted Aug 7, 2012 · Expires Aug 2, 2032

    granted
  13. US 8236829

    Bicyclic derivatives as modulators of voltage gated ION channels

    Vertex Pharmaceuticals Incorporated · Granted Aug 7, 2012 · Expires Aug 2, 2032

    granted
  14. US 8236833

    Biphenyl derivatives as modulators of voltage gated ion channels

    Vertex Pharmaceuticals Incorporated · Granted Aug 7, 2012 · Expires Aug 2, 2032

    granted
  15. US 8236832

    Thiazoles, imidazoles, and pyrazoles useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Aug 7, 2012 · Expires Aug 2, 2032

    granted
  16. US 8232302

    Thiazoles and oxazoles useful as modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Jul 31, 2012 · Expires Jul 26, 2032

    granted
  17. US 8232406

    c-MET protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jul 31, 2012 · Expires Jul 26, 2032

    granted
  18. US 8227615

    Pyridyl derivatives as CFTR modulators

    Vertex Pharmaceuticals Incorporated · Granted Jul 24, 2012 · Expires Jul 19, 2032

    granted
  19. US 8217172

    Solid forms of 1-ethyl-3-(5-(5-fluoropyridin-3-yl)-7-(pyrimidin-2-yl)-1H-benzo[d]imidazol-2-yl)urea

    Vertex Pharmaceuticals Incorporated · Granted Jul 10, 2012 · Expires Jul 5, 2032

    granted
  20. US 8217056

    Triazolothiadiazole inhibitor of c-Met protein kinase

    Vertex Pharmaceuticals Incorporated · Granted Jul 10, 2012 · Expires Jul 5, 2032

    granted
  21. US 8217048

    Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

    Vertex Pharmaceuticals Incorporated · Granted Jul 10, 2012 · Expires Jul 5, 2032

    granted
  22. US 8211935

    Heterocyclic derivatives for modulation of calcium channels

    Vertex Pharmaceuticals Incorporated · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted
  23. US 8202889

    Inhibitors of bacterial IMPDH

    Vertex Pharmaceuticals Incorporated · Granted Jun 19, 2012 · Expires Jun 14, 2032

    granted
  24. US 8202861

    Compositions useful as inhibitors of voltage-gated sodium channels

    Vertex Pharmaceuticals Incorporated · Granted Jun 19, 2012 · Expires Jun 14, 2032

    granted